Funder
Ultragenyx Pharmaceutical
This work has received support from Ultragenyx for medical writing and figure creation.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference10 articles.
1. Marsden D, Bedrosian CL, Vockley J. Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders. Genet Med. 2021;23:816–29.
2. Spiekerkoetter U, Vockley J. Mitochondrial fatty acid oxidation defects. In: Blau N, Dionisi-Vici C, Ferreira CR, Vianey-Saban C, van Karnebeek CDM editors, Physician’s guide to the diagnosis, treatment and follow-up of inherited disorders. Switzerland: Springer Nature; 2022, pp 929–57.
3. Aldubayan SH, Rodan LH, Berry GT, Levy HL. Acute illness protocol for fatty acid oxidation and carnitine disorders. Pediatr Emerg Care. 2017;33:296–301.
4. Grünert SC, Eckenweiler M, Haas D, Lindner M, Tsiakas K, Santer R, et al. The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein. J Inherit Metab. 2021;44:893–902.
5. Fletcher AL, Pennesi ME, Harding CO, Weleber RG, Gillingham MB. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol Genet Metab. 2012;106:18–24.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献